A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia (Q43687393)
Jump to navigation
Jump to search
scientific article published in July 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia |
scientific article published in July 2001 |
Statements
1 reference
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia (English)
1 reference
Tefferi A
1 reference
Call TG
1 reference
Mesa RA
1 reference
Elliott MA
1 reference
Hoagland HC
1 reference
Schroeder GS
1 reference
Yoon SY
1 reference
Li CY
1 reference
Gray LA
1 reference
Margolin S
1 reference
Hook CC
1 reference
1 July 2001
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference